New drug combo shows promise for rare penile cancer

NCT ID NCT00210041

Completed Disease control Sponsor: Institut Claudius Regaud Source: ClinicalTrials.gov ↗

First seen May 21, 2026 · Last updated May 21, 2026

Summary

This study tested whether a combination of two chemotherapy drugs, gemcitabine and cisplatin, can shrink tumors in people with advanced or metastatic penile cancer. Fifty adults with inoperable or spread cancer received the drug combo. The goal was to see how many patients responded and to check side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENITAL NEOPLASMS, MALE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

CHU Grenoble

Grenoble, France
Centre Eugène Marquis

Rennes, France
Centre François Baclesse

Caen, France
Centre Léon Bérard

Lyon, France
Centre Médico-Chirurgical Foch

Suresnes, France
Centre Paul Papin

Angers, France
Institut Bergonie

Bordeaux, France
Institut Claudius Regaud

Toulouse, France
Institut Curie

Paris, France
Institut Paoli Calmette

Marseille, France
Institut Val d'aurelle

Montpellier, France

Conditions

Explore the condition pages connected to this study.

GENITAL NEOPLASMS, MALE